EQS-News

VARON Oxygen Concentrators Meet Rising Demand for Modern Oxygen Therapy in Germany 11.04.2026, 16:30 Uhr von EQS News Jetzt kommentieren: 0

EQS-News: Varon oxygen concentrator / Key word(s): Miscellaneous
VARON Oxygen Concentrators Meet Rising Demand for Modern Oxygen Therapy in Germany

11.04.2026 / 16:30 CET/CEST
The issuer is solely responsible for the content of this announcement.


BERLIN, April 11, 2026 /PRNewswire/ -- As respiratory care needs continue to rise across Germany, demand is increasing for safer, quieter, and more efficient oxygen therapy solutions. More users are shifting away from traditional systems such as oxygen tanks and conventional home oxygen device and moving toward advanced oxygen concentrators designed for mobility, comfort, and continuous medical support.

VARON addresses this growing need with two medical-grade solutions: the portable VP-8G and the home-use Serene 5.

Portable Oxygen Freedom with VARON VP-8G

The VP-8G portable oxygen concentrator is designed for users seeking independence from heavy oxygen equipment. As a modern alternative, it delivers reliable oxygen support in a lightweight and travel-friendly design.

Key features include:

  • Ultra-lightweight design at only 1.98 kg
  • 8-level pulse flow (1–8 settings)
  • Oxygen purity of 93% ± 3%
  • Breath-controlled pulse and fixed-frequency modes
  • Quiet operation (≤40dB at setting Level 1)
  • Replaceable battery for extended mobility
  • Compact carrying system for daily use

The VP-8G supports active lifestyles by allowing users to receive continuous oxygen therapy at home, outdoors, and while traveling.

Home Oxygen Therapy with VARON Serene 5

The Serene 5 oxygen concentrator is built for continuous oxygen therapy at home, offering a modern home oxygen device.

Key features include:

  • Medical-grade oxygen output at 93% ± 3%
  • Adjustable flow rate from 0.5 to 5 L/min
  • Ultra-quiet operation below 43 dB
  • Up to 72 hours continuous operation capability
  • Integrated 2-in-1 nebulizer function
  • LCD control panel with safety alerts
  • Easy mobility with built-in wheels

The Serene 5 is suitable for elderly users, patients with chronic respiratory conditions, pregnant women, and individuals requiring long-term oxygen support. It also works with CPAP/BiPAP therapy systems for sleep apnea management.

Growing Demand for Oxygen Therapy Solutions

Germany is experiencing a shift toward home-based healthcare and portable medical devices. This trend is driving increased demand for modern oxygen concentrators that replace outdated oxygen systems.

Both the VP-8G and Serene 5 provide a more efficient alternative to the traditional oxygen tanks offering greater portability, safety, and ease of use.

About VARON

VARON develops advanced oxygen therapy solutions designed to improve mobility, independence, and quality of life. With a focus on performance, quiet operation, and user-friendly design, VARON support modern respiratory care needs in Germany and worldwide.

Media Contact:

VARON Oxygen Concentrators

Email: support@varoninc.de 

Website: https://varoninc.de/ 

Cision View original content:https://www.prnewswire.com/de/pressemitteilungen/varon-oxygen-concentrators-meet-rising-demand-for-modern-oxygen-therapy-in-germany-302739759.html

rt.gif?NewsItemId=EN31523&Transmission_Id=202604111027PR_NEWS_EURO_ND__EN31523&DateId=20260411


11.04.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2306746  11.04.2026 CET/CEST

Kommentare (0) ... diskutiere mit.
Werbung

Handeln Sie Aktien bei SMARTBROKER+ für 0 Euro!* Profitieren Sie von kostenloser Depotführung, Zugriff auf 29 deutsche und internationale Börsenplätze und unschlagbar günstigen Konditionen – alles in einer innovativen, brandneuen App. Jetzt zu SMARTBROKER+ wechseln und durchstarten!

*Ab 500 EUR Ordervolumen über gettex. Zzgl. marktüblicher Spreads und Zuwendungen.

k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer